Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Authorized is not Outstanding....

Re: Authorized is not Outstanding.... ask yourself this,

posted on Sep 14, 2008 10:35AM

re: B-Lunist, "This is dilution if and only if the shares do not return value to the retail shareholders."

In a sense this is true.

But one could argue that the financial impact to stockholders would be about the same if we just all sent them 20% cash. In either case, we send control of cash/stock to PTSC and the implied reason for the cash/stock-printing infusion is to somehow increase stockholder value. If they succeed we'd be equally well off as a result. Of course no one is likey to send cash. And, as you imply, those of us that don't like the dilution don't really have a choice about contributing 20% of our stocck to the cause.

Seasoned investors will be looking at the quantity of both "authorized" and "outstanding" shares. So I don't think this is much consulation.

Will the return be at least 20% within the next year? We can only hope, but that's a very big return.



Share
New Message
Please login to post a reply